McEwen will acquire this strategic investment by purchasing 648,002 shares of Paragon from Britannia Life Sciences Inc. and 226,286 shares from Paragon via a private placement, both at a deemed price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback